HeimHESTERBIO • NSE
add
Hester Biosciences Ltd
Við síðustu lokun
1.782,90 ₹
Dagbil
1.740,70 ₹ - 1.795,00 ₹
Árabil
1.242,95 ₹ - 3.379,00 ₹
Markaðsvirði
14,99 ma. INR
Meðalmagn
64,53 þ.
V/H-hlutf.
47,02
A/V-hlutfall
0,34%
Aðalkauphöll
NSE
Viðskiptafréttir
The Washington Post
fyrir 12 klukkustundum
Markets erase April losses as jobs report fuels stock gains
1,47%
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (INR) | des. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 710,27 m. | 4,49% |
Rekstrarkostnaður | 428,23 m. | 7,22% |
Nettótekjur | 116,62 m. | 192,72% |
Hagnaðarhlutfall | 16,42 | 180,20% |
Hagnaður á hvern hlut | — | — |
EBITDA | 127,96 m. | 2,42% |
Virkt skatthlutfall | 14,65% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (INR) | des. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 167,88 m. | 16,16% |
Heildareignir | — | — |
Heildarskuldir | — | — |
Eigið fé alls | 3,14 ma. | — |
Útistandandi hlutabréf | 8,70 m. | — |
Eiginfjárgengi | 4,91 | — |
Arðsemi eigna | — | — |
Ávöxtun eigin fjár | 3,84% | — |
Peningaflæði
Breyting á handbæru fé
| (INR) | des. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | 116,62 m. | 192,72% |
Handbært fé frá rekstri | — | — |
Reiðufé frá fjárfestingum | — | — |
Reiðufé frá fjármögnun | — | — |
Breyting á handbæru fé | — | — |
Frjálst peningaflæði | — | — |
Um
Hester Biosciences Limited is a publicly traded Indian animal and poultry vaccines manufacturing company, headquartered in Ahmedabad. Hester has plants situated in Gujarat and Nepal. Hester has a 30% share of the poultry vaccines market in India, making it the country's second largest poultry vaccine manufacturer. Hester is also the first commercial manufacturer of goat pox vaccine in India and manufactures PPR vaccines from both, Nigerian and Sungri strains. Wikipedia
Stofnsett
1983
Vefsvæði
Starfsfólk
642
